JP6404211B2 - 体外血液改質のためのシステムおよび方法 - Google Patents

体外血液改質のためのシステムおよび方法 Download PDF

Info

Publication number
JP6404211B2
JP6404211B2 JP2015512646A JP2015512646A JP6404211B2 JP 6404211 B2 JP6404211 B2 JP 6404211B2 JP 2015512646 A JP2015512646 A JP 2015512646A JP 2015512646 A JP2015512646 A JP 2015512646A JP 6404211 B2 JP6404211 B2 JP 6404211B2
Authority
JP
Japan
Prior art keywords
antibody
polymer
antigen
subject
blood
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
JP2015512646A
Other languages
English (en)
Japanese (ja)
Other versions
JP2015516264A5 (enExample
JP2015516264A (ja
Inventor
マカルヴィン，ジェームス，ビー．
ミズラヒ，ボアズ
コーエン，ダニエル，エス．
ワイリー，ライアン，ジー．
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Boston Childrens Hospital
Original Assignee
Boston Childrens Hospital
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Boston Childrens Hospital filed Critical Boston Childrens Hospital
Publication of JP2015516264A publication Critical patent/JP2015516264A/ja
Publication of JP2015516264A5 publication Critical patent/JP2015516264A5/ja
Application granted granted Critical
Publication of JP6404211B2 publication Critical patent/JP6404211B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M1/00—Suction or pumping devices for medical purposes; Devices for carrying-off, for treatment of, or for carrying-over, body-liquids; Drainage systems
    • A61M1/36—Other treatment of blood in a by-pass of the natural circulatory system, e.g. temperature adaptation, irradiation ; Extra-corporeal blood circuits
    • A61M1/362—Other treatment of blood in a by-pass of the natural circulatory system, e.g. temperature adaptation, irradiation ; Extra-corporeal blood circuits changing physical properties of target cells by binding them to added particles to facilitate their subsequent separation from other cells, e.g. immunoaffinity
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L29/00—Materials for catheters, medical tubing, cannulae, or endoscopes or for coating catheters
    • A61L29/04—Macromolecular materials
    • A61L29/06—Macromolecular materials obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L29/00—Materials for catheters, medical tubing, cannulae, or endoscopes or for coating catheters
    • A61L29/14—Materials characterised by their function or physical properties, e.g. lubricating compositions
    • A61L29/16—Biologically active materials, e.g. therapeutic substances
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M1/00—Suction or pumping devices for medical purposes; Devices for carrying-off, for treatment of, or for carrying-over, body-liquids; Drainage systems
    • A61M1/36—Other treatment of blood in a by-pass of the natural circulatory system, e.g. temperature adaptation, irradiation ; Extra-corporeal blood circuits
    • A61M1/3618—Magnetic separation
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M1/00—Suction or pumping devices for medical purposes; Devices for carrying-off, for treatment of, or for carrying-over, body-liquids; Drainage systems
    • A61M1/36—Other treatment of blood in a by-pass of the natural circulatory system, e.g. temperature adaptation, irradiation ; Extra-corporeal blood circuits
    • A61M1/3679—Other treatment of blood in a by-pass of the natural circulatory system, e.g. temperature adaptation, irradiation ; Extra-corporeal blood circuits by absorption
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M5/00—Devices for bringing media into the body in a subcutaneous, intra-vascular or intramuscular way; Accessories therefor, e.g. filling or cleaning devices, arm-rests
    • A61M5/14—Infusion devices, e.g. infusing by gravity; Blood infusion; Accessories therefor
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
    • A61L2300/20—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices containing or releasing organic materials
    • A61L2300/252—Polypeptides, proteins, e.g. glycoproteins, lipoproteins, cytokines
    • A61L2300/256—Antibodies, e.g. immunoglobulins, vaccines

Landscapes

  • Health & Medical Sciences (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Vascular Medicine (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Biomedical Technology (AREA)
  • Engineering & Computer Science (AREA)
  • Anesthesiology (AREA)
  • Hematology (AREA)
  • Cardiology (AREA)
  • Epidemiology (AREA)
  • Chemical & Material Sciences (AREA)
  • Immunology (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • External Artificial Organs (AREA)
JP2015512646A 2012-05-14 2013-03-14 体外血液改質のためのシステムおよび方法 Active JP6404211B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201261646674P 2012-05-14 2012-05-14
US61/646,674 2012-05-14
PCT/US2013/031744 WO2013172966A1 (en) 2012-05-14 2013-03-14 Systems and methods for extracorporeal blood modification

Publications (3)

Publication Number Publication Date
JP2015516264A JP2015516264A (ja) 2015-06-11
JP2015516264A5 JP2015516264A5 (enExample) 2016-05-12
JP6404211B2 true JP6404211B2 (ja) 2018-10-10

Family

ID=49584139

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2015512646A Active JP6404211B2 (ja) 2012-05-14 2013-03-14 体外血液改質のためのシステムおよび方法

Country Status (5)

Country Link
US (3) US20150132312A1 (enExample)
EP (1) EP2849817B1 (enExample)
JP (1) JP6404211B2 (enExample)
ES (1) ES2725573T3 (enExample)
WO (1) WO2013172966A1 (enExample)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2013181016A2 (en) * 2012-05-27 2013-12-05 Felder Mitchell S Treatment for the rapid amelioration of clinical depression
KR102271653B1 (ko) * 2013-06-07 2021-07-05 백스터 인터내셔널 인코포레이티드 트리하이드록시페닐기를 포함하는 화합물을 사용한 기판 상에의 활성제의 고정화
MX369551B (es) * 2013-12-27 2019-11-12 Eliaz Therapeutics Inc Dispositivo de plasmaferesis.
DE102015207228A1 (de) * 2015-04-21 2016-10-27 Vetter Pharma-Fertigung GmbH & Co. KG Primärpackmittel und Verfahren zur Herstellung eines Primärpackmittels
US10064653B2 (en) 2015-06-08 2018-09-04 The Board Of Trustees Of The Leland Stanford Junior University Intravascular magnetic wire for detection, retrieval or elimination of disease-associated biomarkers and toxins
EP3735281B1 (en) 2018-01-05 2024-11-27 Path Ex, Inc. Device for the capture and removal of disease material from fluids
EP4028071A4 (en) * 2019-09-13 2024-03-13 The Trustees of Indiana University Devices and methods for modulating adma in blood
US20230148395A1 (en) * 2020-04-08 2023-05-11 Arizona Board Of Regents On Behalf Of Arizona State University Covid-19 inflammatory cytokine storm treatment
CN112090410B (zh) * 2020-07-29 2023-11-10 健帆生物科技集团股份有限公司 具有互穿网络包膜的血液净化吸附剂、制备方法及灌流器
WO2024030085A1 (en) * 2022-08-05 2024-02-08 Innowayrg Arastirma Gelistirme Ve Danismanlik Hizmetleri Sanayi Ve Ticaret Anonim Sirketi A device for cleaning heavy metal-bound mediators in body fluids and organs
WO2024076704A1 (en) * 2022-10-05 2024-04-11 Immunicom, Inc. Il-6 removal
KR102694305B1 (ko) * 2023-05-23 2024-08-13 주식회사 월드바이오텍 치열교정 브라켓

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3523615A1 (de) * 1985-07-02 1987-01-15 Cytomed Medizintechnik Medizinisches geraet, insbesondere kanuele, katheter oder implantat
US5589563A (en) * 1992-04-24 1996-12-31 The Polymer Technology Group Surface-modifying endgroups for biomedical polymers
JP4662665B2 (ja) * 1999-06-03 2011-03-30 アドバンスト エクストラバスキュラー システムズ 循環血液からの好ましくない分子の一段階除去
US6969367B2 (en) * 2000-02-02 2005-11-29 Xepmed, Inc. Extracorporeal pathogen reduction system
US20030120202A1 (en) * 2001-12-21 2003-06-26 Gordon Lucas S. Magnetic extracorporeal circuit for removal of medical agents
US20040028687A1 (en) * 2002-01-15 2004-02-12 Waelti Ernst Rudolf Methods and compositions for the targeted delivery of therapeutic substances to specific cells and tissues
US8211310B2 (en) * 2006-11-20 2012-07-03 Cytosorbents, Inc. Size-selective polymer system
US20090191175A1 (en) * 2006-11-21 2009-07-30 University Of Southern California Therapeutic methods using peg-conjugated agents and devices for performing the same
WO2009079664A1 (en) * 2007-12-19 2009-06-25 Georgia Tech Research Corporation Modification of biomaterials with microgel films
KR20110025975A (ko) * 2008-06-17 2011-03-14 조지아 테크 리서치 코오포레이션 세포, 병원체 또는 바이러스의 제거를 위한 초상자성 나노입자
US8454547B2 (en) * 2009-02-25 2013-06-04 The Invention Science Fund I, Llc Device, system, and method for controllably reducing inflammatory mediators in a subject
CA2776613A1 (en) * 2009-10-07 2011-04-14 University Of Pittsburgh - Of The Commonwealth System Of Higher Educatio N Devices, systems and methods for cell modification
WO2011112873A2 (en) * 2010-03-10 2011-09-15 Paul Tebbey Extracorporeal immunoadsorption treatment

Also Published As

Publication number Publication date
EP2849817A4 (en) 2016-01-20
US20200171232A1 (en) 2020-06-04
EP2849817A1 (en) 2015-03-25
US20200101214A1 (en) 2020-04-02
JP2015516264A (ja) 2015-06-11
ES2725573T3 (es) 2019-09-24
US20150132312A1 (en) 2015-05-14
WO2013172966A1 (en) 2013-11-21
EP2849817B1 (en) 2019-03-13

Similar Documents

Publication Publication Date Title
JP6404211B2 (ja) 体外血液改質のためのシステムおよび方法
US9964541B2 (en) Method and devices for capturing circulating tumor
Myerson et al. Flexible nanoparticles reach sterically obscured endothelial targets inaccessible to rigid nanoparticles
Agyare et al. Development of a smart nano-vehicle to target cerebrovascular amyloid deposits and brain parenchymal plaques observed in Alzheimer’s disease and cerebral amyloid angiopathy
Brenner et al. Red blood cell-hitchhiking boosts delivery of nanocarriers to chosen organs by orders of magnitude
US10900969B2 (en) Biomimetic microfluid device for capturing circulating tumor cells
JPH02504635A (ja) 生体特異性ポリマー
US20180016352A1 (en) Targeting constructs for delivery of payloads
Lou et al. Fabrication of magnetic conjugation clusters via intermolecular assembling for ultrasensitive surface plasmon resonance (SPR) detection in a wide range of concentrations
Wang et al. Carboxybetaine methacrylate-modified nylon surface for circulating tumor cell capture
Ahmed et al. Molecular imaging of a new multimodal microbubble for adhesion molecule targeting
Vorobii et al. Antifouling microparticles to scavenge lipopolysaccharide from human blood plasma
Tian et al. Zwitterionic poly (ethylene glycol) nanoparticles minimize protein adsorption and immunogenicity for improved biological fate
KR0142876B1 (ko) 자성 단백질 결합체, 이의 제조방법, 및 이의 용도
CN109893530A (zh) Vista小分子激动剂的医药用途及其药物组合物
CN116194164A (zh) 用于治疗败血症的透析系统
Ji et al. Inhibition of tumor immune escape by blocking PD-1/PD-L1 engagement with dual-targeting molecularly imprinted polymer layer
CA3154234A1 (en) Non-hemolytic compositions and methods of use for recovering disease causing toxic constituents in the blood
Okuno et al. A Novel Surface Modification and Immobilization Method of Anti-CD25 Antibody on Nonwoven Fabric Filter Removing Regulatory T Cells Selectively
Milivojević et al. Evaluation of novel dendrimer–gold complex nanoparticles for theranostic application in oncology
Pawar et al. Effect of Uremic Toxins and Methoxy-PEO Chain Density on Plasma Protein Adsorption
Alikhani et al. High molecular weight blood group A trisaccharide‐polyacrylamide glycoconjugates as synthetic blood group A antigens for anti‐A antibody removal devices
US10765881B2 (en) Magnetic particle conjugates and methods of activating cell signaling
Calon The duality of the BBB: breaking the myth of the blood-brain barrier breakdown
Kerby et al. Circulating IgSF proteins inhibit adhesion of antibody targeted microspheres to endothelial inflammatory ligands

Legal Events

Date Code Title Description
A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20160314

A621 Written request for application examination

Free format text: JAPANESE INTERMEDIATE CODE: A621

Effective date: 20160314

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20170131

A977 Report on retrieval

Free format text: JAPANESE INTERMEDIATE CODE: A971007

Effective date: 20170131

A601 Written request for extension of time

Free format text: JAPANESE INTERMEDIATE CODE: A601

Effective date: 20170501

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20170630

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20171130

A601 Written request for extension of time

Free format text: JAPANESE INTERMEDIATE CODE: A601

Effective date: 20180228

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20180328

TRDD Decision of grant or rejection written
A01 Written decision to grant a patent or to grant a registration (utility model)

Free format text: JAPANESE INTERMEDIATE CODE: A01

Effective date: 20180820

A61 First payment of annual fees (during grant procedure)

Free format text: JAPANESE INTERMEDIATE CODE: A61

Effective date: 20180912

R150 Certificate of patent or registration of utility model

Ref document number: 6404211

Country of ref document: JP

Free format text: JAPANESE INTERMEDIATE CODE: R150

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250